NPC1L1 and breast cancer: Estimates for NPC1L1 were suggestive of risk-increasing effects of raised LDL-cholesterol on breast cancer and ER-positive breast cancer risk in inverse variance-weighted analysis, but MR Egger estimates were in the opposite direction, casting doubt on the validity of MR assumptions in this case.